INTRODUCTION
============

p53 is a transcription factor that coordinates cellular responses to stress, such as cell cycle arrest, DNA repair, senescence, and apoptosis ([@B92]). *TP53* is the most frequently mutated gene in human cancers. Most cancer-associated p53 mutations occur in its DNA-binding domain, suggesting that p53 DNA binding and associated gene regulation are crucial in tumor suppression ([@B22]). Numerous genome-scale studies have characterized p53 transcriptional programs and, in a comprehensive literature survey, we found a total of 30 peer-reviewed studies that combine binding and expression data sets ([@B31]; [@B11]; [@B93]; [@B80]; [@B82]; [@B42]; [@B5]; [@B8]; [@B7]; [@B44], [@B46]; [@B62]; [@B34]; [@B57]; [@B78]; [@B100][;]{.ul} [@B3]; [@B13]; [@B26]; [@B29]; [@B55]; [@B73]; [@B77]; [@B37]; [@B76]; [@B85]; [@B89]; [@B98][;]{.ul} [@B87]). Although these have provided powerful insights into general p53 functions, the majority were performed in immortalized/cancer cell lines, which limits insights to proliferative contexts often associated with distortions in the p53 regulatory network itself. In addition, p53 can be activated by diverse stressors, including extended cell culture ([@B80]; [@B8]). Among all these comprehensive genome-scale studies, only two compared tissue-specific stress programs in vivo ([@B89]; [@B87]). Given that p53 mutations are associated with a variety of cancers, in vivo studies are ideal to dissect the mechanisms that modulate p53 function to specific cellular environments, hence tissue-specific actions of p53 are likely important for its potent tumor suppressive capability.

Early studies demonstrated that p53 regulatory axes can be uncoupled from one another. For example, the p53^175P^ point mutation abolishes apoptotic responses but has no effect on p53-mediated cell cycle arrest ([@B75]). Recently three key lysine residues have been identified as crucial for p53-mediated apoptosis, cell cycle arrest, and senescence ([@B45]). Strikingly, the combined abrogation of these three pathways, through p53 lysine mutations or combined knockout of p53 downstream targets, is not sufficient to recapitulate early onset cancer phenotypes observed in p53 null mice ([@B45]; [@B91]). Together these observations establish that noncanonical p53 programs are crucial for tumor suppression.

*Drosophila* has proven to be a powerful in vivo model for investigating p53 biology ([@B52]; [@B53]; [@B49]; [@B58]; [@B95]; [@B27]). In addition to the array of genetic tools that allow for rigorous in vivo studies, p53 function is highly conserved in *Drosophila*, and it is the only member of this gene family present in the fly genome ([@B86]; [@B6]; [@B51]). Previously, we and others described p53 stress-programs of gene regulation in embryos ([@B9]; [@B83]; [@B2]). Here we examine the adult *Drosophila* head as a model for p53 function in tissues that are almost entirely postmitotic and where p53 was previously shown to be active ([@B58]). Interestingly, we found that canonical stress-induced apoptotic networks are unresponsive in postmitotic tissue and instead distinct programs are activated. To understand how p53 promotes alternate programs, we established that constitutive occupancy at a pivotal p53 enhancer correlates with apoptogenic outcomes. Furthermore, we mapped genome-wide p53 DNA occupancy in both the developing and the postmitotic tissues and integrated these with RNA-seq profiles. To our knowledge, these analyses constitute the first genome-scale profile integrating p53 binding and transcriptional regulation in *Drosophila melanogaster.*

RESULTS
=======

Canonical p53 apoptotic programs are unresponsive in postmitotic tissue
-----------------------------------------------------------------------

Like its human counterpart, *Drosophila* p53 can direct transcriptional programs to promote adaptive responses to various cellular stresses, including apoptosis ([@B9]; [@B65]). In *Drosophila* embryos, ionizing radiation (IR) stress has been characterized as a potent inducer of p53-mediated apoptosis ([@B83]). Interestingly, induction of p53-mediated apoptosis appears to be highly sensitive to cell type and cell-cycle modifications, for example, endocycling cells of *Drosophila* larval salivary glands fail to up-regulate cell death upon DNA damage, underscoring the context specificity of p53-regulated programs ([@B60], [@B59]; [@B17]; [@B101]; [@B4]; [@B68]). Furthermore, recent reports have shown that expression of human tau in *Drosophila* neurons leads to DNA damage and apoptosis ([@B35]). Surprisingly, p53 loss enhances tau-mediated apoptosis in *Drosophila* postmitotic neurons ([@B58]). Therefore, we hypothesized that in postmitotic tissue, p53 does not activate cell death in response to IR. To test this hypothesis, we exposed flies to IR and quantified cell death by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) in both embryos and adult brains ([Figure 1](#F1){ref-type="fig"}, A and B). As expected, in embryos, a robust apoptotic wave can be detected following IR. In brains, by contrast, no significant increase in TUNEL-positive cells was observed. Samples treated with DNase were used as positive control, and samples in which no terminal deoxynucleotidyl transferase (TdT) enzyme was added served as the negative control (Supplemental Figure S1, A and B). These results suggest canonical apoptotic programs triggered by p53 are nonresponsive in postmitotic tissue.The proapoptotic genes Head Involution Defective (*hid*), Reaper (*rpr*), and Sickle (*skl*) are among the most robust stress-induced p53 targets in embryos ([@B10]; [@B2]), and furthermore, when these genes are collectively removed, virtually all stress-dependent and programmed cell death is abolished ([@B94]). Therefore, to determine whether the proapoptotic p53 program can be transcriptionally activated in postmitotic tissue, we tested for up-regulation of these apoptogenic genes in *Drosophila* heads 1, 3, 5, and 8 h post-IR exposure using previously described reverse transcription-droplet digital PCR (RT-ddPCR) assays ([@B49]). Interestingly, all three cell death genes were unresponsive up to 8 h post-IR ([Figure 1](#F1){ref-type="fig"}C) and, as technical controls, we reproduced induction of *hid*, *rpr,* and *skl* on embryonic RNAs, as previously reported (Supplemental Figure S1C) ([@B10]; [@B2]; [@B49]). To exclude the possibility that apoptotic genes are nonresponsive in heads due to a lack of p53 (or low p53), we examined nuclear lysates by performing Western blots. As seen in Supplemental Figure S2B, we found that p53 protein is readily detected in heads even before IR treatment. Therefore, p53 absence does not account for a lack of damage-induced apoptosis in this tissue. We also tested IR activation of other known embryonic p53 targets, *xrp1* and *ku80*. In contrast to embryo tissue, where x*rp1* is rapidly induced over 10-fold following IR, no up-regulation above twofold was observed in postmitotic tissue. However, within 3 h of IR challenge, robust induction of *ku80* was detected in head tissue. To test whether p53 mediates activation of *ku80* in heads, we repeated the RT-ddPCR experiment at the 3-h time point to include p53^−/−^ heads ([Figure 1](#F1){ref-type="fig"}D). Notably, *ku80* induction was lost in p53^−/−^ animals and, confirming our time course results, all cell death genes remained unresponsive in wild type (WT) and p53^−/−^. Therefore, p53 is required for *ku80* induction in postmitotic tissue. Together these results establish that the apoptotic program triggered by p53 in irradiated embryos is unresponsive in postmitotic tissue.

![The p53 apoptotic program is unresponsive in postmitotic tissue. (A) TUNEL labeling in *Drosophila* WT embryos and brains, with and without IR stress (scale bar = 50 µm). (B) Quantification of TUNEL positive cells (mean values represented with SD, *n* = 3). (C) Expression time course for indicated genes following IR stress measured by RT-ddPCR from WT head tissue (mean values represented with SD, *n* = 3). Note that all five genes are known p53 targets in IR-treated embryos. (D) RT-ddPCR for indicated genes 3 h post-IR in head tissue of WT and p53^−/−^ animals.](mbc-30-1339-g001){#F1}

Occupancy at the p53 *rpr* enhancer predicts activation of apoptotic program
----------------------------------------------------------------------------

To understand why apoptogenic genes in the *reaper* region are unresponsive in postmitotic tissue, we focused on a well-characterized p53 response element ∼5 kb upstream of *rpr* (referred to as p53RE^rpr^) ([@B9]). Genetic ablation of the p53RE^rpr^ eliminates stress-induced activation of *rpr* as well as *hid* and *skl* (a genomic region spanning more than 300 kb) ([@B49]). Strikingly, this enhancer is also required for activation of genes in *trans* such as *xrp1* and *ku80* ([@B48]; [@B49]). Long-range regulation of these p53 targets is accomplished through chromatin contacts that link the p53RE^rpr^ and the cell death genes ([@B49]). Therefore, we hypothesized that altered or diminished looping of this enhancer might preclude p53-mediated activation of cell death genes at this locus. To test this hypothesis, we examined chromatin folding through the *reaper* region by applying our previously published digital-3C assay on chromatin prepared from heads ([@B49]). We found that the chromosome conformation pattern through the entire locus was well preserved in heads ([Figure 2](#F2){ref-type="fig"}A) when compared with the pattern seen in embryos ([@B49]). Therefore, failure to activate cell death genes in heads is not explained by substantial alterations of p53 enhancer contacts.

![p53 binding at the *rpr* enhancer is lost in postmitotic tissue. (A) 3C-ddPCR experiments in *Drosophila* head tissue. Interactions between the p53RE^rpr^ (green) and IR induced cell death p53 targets (red) were measured. Note that the p53RE^rpr^ looping pattern is very similar to published patterns from embryos ([@B49]). B and B' show ChIP-ddPCR experiments measuring p53 occupancy at the p53RE^rpr^ in embryo and head tissue. Note that patterns were reproduced using ChIP-seq ([Figure 4](#F4){ref-type="fig"}). Positive and negative control regions corresponding to the p53 promoter and p53 3′UTR were included ([@B58]). Values represent fold change over immunoprecipitation using IgG. Mean values represented with SD, (A) *n* = 3, (B) *n* = 2 (see ChIP methods).](mbc-30-1339-g002){#F2}

An alternative hypothesis that could explain how the response of *reaper* region genes is distinct in the two tissues invokes p53 occupancy at the p53RE^rpr^. To test this hypothesis, we measured p53 binding at the p53RE^rpr^ through chromatin immunoprecipitation (ChIP)-ddPCR assays on embryo and head samples using established positive and negative regions (p53 promoter and p53 3′UTR, respectively) as our benchmarks ([@B58]). Since p53 is often prebound to response elements prior to stress-induced target activation ([@B42]; [@B58]; [@B89]), these ChIP experiments were conducted without perturbation. As seen in [Figure 2](#F2){ref-type="fig"}B, we detected p53 binding to the p53RE^rpr^ in embryonic samples consistent with earlier studies ([@B58]). However, in stark contrast, the p53RE^rpr^ was not bound by p53 in adult heads ([Figure 2](#F2){ref-type="fig"}B'). Taken together, these results indicate that apoptogenic genes may be unresponsive because p53 does not occupy the p53RE^rpr^ in postmitotic tissue.

Genome-wide p53 DNA occupancy
-----------------------------

Given that p53RE^rpr^ occupancy is distinct in proliferative versus postmitotic tissues, we hypothesized that unique enhancer networks enable p53 to direct tissue-specific responses. To characterize genome-wide p53 DNA binding, we performed ChIP in embryos and heads, followed by high throughput sequencing (ChIP-seq). To ensure the biological validity of p53-enriched regions, we also performed ChIP-seq in corresponding p53^−/−^ samples processed in parallel. From these data sets, authentic p53 peaks were called by comparing ChIP signals in WT and p53^−/−^ tissue. In addition, we confirmed the ChIP-seq quality by assessing the previously described p53-binding site at the p53 gene promoter ([Figure 3](#F3){ref-type="fig"}A) ([@B58]). A total of 135 p53-enriched regions in embryos (e-peaks) and 392 in heads (h-peaks) were identified at FDR of 0.05. Interestingly, 75 regions had p53 enrichment in both tissues ([Figure 3](#F3){ref-type="fig"}B). Additionally, a significant portion of called peaks contained the highly conserved p53-binding motif (in heads, 25.8%; embryos, 24.4%) and, as seen in [Figure 3](#F3){ref-type="fig"}, C and C', a majority of p53-binding sites in both heads (61.5%) and embryos (78.3%) were found within 5 kb of a transcription start site (TSS). We also confirmed these results by directly measuring p53 peaks of varying enrichment using ChIP-ddPCR on newly prepared chromatin from heads and, as seen in Supplemental Figure S3, all peaks tested were validated (*N* = 6).

![p53 genome-wide binding profiles in *Drosophila* embryos and heads. (A) ChIP-seq detects a published p53-enriched region at the promoter of p53 gene ([@B58]). Graph displays fold enrichment over p53^−/−^ samples (for normalized tracks including the p53^−/−^ see Supplemental Figure S3). (B) Venn diagram of ChIP-seq p53 called peaks shared and distinct among the indicated tissues. (C, C') Distribution of p53 peaks by distance between the peak and the closest TSS (C in embryos and C' in heads).](mbc-30-1339-g003){#F3}

Consistent with results from our ChIP-ddPCR assays ([Figure 2](#F2){ref-type="fig"}, B and B'), our ChIP-seq data sets detected p53 binding at the p53RE^rpr^ in embryos but not in heads ([Figure 4](#F4){ref-type="fig"}A). In addition, p53 enrichment was detected at the canonical targets *hid* and *xrp1* not only in embryos but, surprisingly, also in heads where these genes fail to activate on IR ([Figure 4](#F4){ref-type="fig"}, B and C). Therefore, p53 binding at each of these two genes is not sufficient to predict stimulus-induced gene activation; consistent with indications that other elements contribute to activation of *hid* and *xrp1* in irradiated embryos ([@B49]).

![Binding at *rpr* is lost in postmitotic tissue among canonical stress-induced embryonic targets. (A) ChIP-seq confirms that p53 occupies the p53RE^rpr^ in embryos but not in heads. (B, C) p53-enriched regions in *hid* and *xrp1* are detected in both tissues, although these genes are responsive only in embryos. All graphs display fold enrichment over p53^−/−^ samples (for normalized tracks including the p53^−/−^, see Supplemental Figure S3).](mbc-30-1339-g004){#F4}

To infer programs potentially engaged by p53, we identified genes within 5 kb of a p53-enriched region and performed pathway enrichment analyses using the gene ontology enRIchment analysis (GOrilla) web tool (Supplemental Tables S1 and S2) ([@B16]). The 5-kb interval was chosen based on distance between *reaper* and the p53RE^rpr^ enhancer. Apoptotic pathway components were enriched near embryonic peaks (Supplemental Table S1), but this was not seen for p53-binding profiles in heads (Supplemental Table S2).

p53 promotes alternate IR-induced programs in postmitotic tissue
----------------------------------------------------------------

Although p53 does not induce stress-responsive apoptosis in postmitotic tissue, we observed p53-dependent induction of the DNA repair gene *ku80* ([Figure 1](#F1){ref-type="fig"}, C and D) and p53 binding in 392 regions ([Figure 3](#F3){ref-type="fig"}B). Therefore, we hypothesized that p53 directs DNA damage response programs in postmitotic tissues. To determine the full scope of p53 transcriptional effects, we measured genome-wide expression changes provoked by IR in WT and p53^−/−^ *Drosophila* heads through paired-end RNA-sequencing experiments. We observed a robust genome-scale p53 transcriptional effect in response to radiation and as expected, p53 IR-dependent gene activation was significantly more prevalent than IR-dependent repression (Supplemental Figure S5, A and B). Strikingly, in postmitotic tissue, nearly all stress-induced gene activation was p53-dependent. After performing differential gene expression analyses, we uncovered 92 [h]{.ul}ead [r]{.ul}adiation-[i]{.ul}nduced [p]{.ul}53-[d]{.ul}ependent (hRIPD) protein-coding genes ([Figure 5](#F5){ref-type="fig"}A). To validate the RNA-seq findings, we selected a set of five genes that have predicted human orthologues (Supplemental File 1) implicated in disease and confirmed p53-mediated IR induction for each using RT-ddPCR ([Figure 5](#F5){ref-type="fig"}B). These assays clearly verified patterns observed in the RNA-seq data sets although the induction amplitudes varied, consistent with the stochastic nature of this perturbation. Next, we annotated the hRIPD genes for the biological process in which they function. Interestingly, the top three biological processes represented by hRIPD genes are metabolism, proteolysis, and DNA repair, including Ku80 and Ku70*,* which are central components of the nonhomologous end joining (NHEJ) pathway*.* However, most hRIPD genes are uncharacterized ([Figure 5](#F5){ref-type="fig"}C); 47% have no functional annotation, 37% have predicted functions, and only 16% have a tested function. Interestingly, we identified a possible novel *Drosophila* DNA repair gene, *CG3448*, which contains a *XRCC4*-like domain. In humans, *XRCC4* binds the NHEJ ligase, *Lig4,* and this complex is responsible for the ligation step of NHEJ. p53-regulated metabolic genes include Adipokinetic hormone (*Akh*), a fly-functional homolog of mammalian glucagon; *Akh* regulates metabolism of carbohydrates, lipids, and glycogen ([@B19]). Intriguingly, studies in mice demonstrated that on starvation, p53 is required for gluconeogenesis and amino acid catabolism ([@B67]). Furthermore, p53 has been implicated in lipid metabolism in the mammalian system ([@B20]). These observations establish the *Drosophila* head as an important in vivo model to study p53 stress-responsive programs.

![Stimulus-dependent p53 transcriptional programs in postmitotic tissue. (A) Heat map of novel p53 postmitotic targets (genes are grouped by biological process), IR fold change as log2 is colored according to legend. (B) RT-ddPCR validation of selected targets from RNA-seq (mean values represented with SD, *n* = 2). (C) Pie chart showing hRIPD genes by functional annotation. (D) The Venn diagram shows distinct and overlapping p53 targets identified in embryos and heads.](mbc-30-1339-g005){#F5}

Originally, embryonic stress-induced profiles were described through microarray methods ([@B10]; [@B2]). To achieve a more comprehensive analysis and to enable direct comparisons with data sets reported here, we performed similar paired-end RNA-sequencing experiments on control and irradiated embryos using previously standardized protocols ([@B10]; [@B2]). After applying the same cutoffs, we identified embryonic radiation-induced p53-dependent (eRIPD) genes (Supplemental Figure S6). As expected, previously reported p53 embryonic targets were detected in our assay, including the proapoptotic program (*rpr*, *skl,* and *hid*). Interestingly, of the 92 hRIPD genes and the 62 eRIPD genes, only a small subset of 11 genes was shared by both tissues ([Figure 5](#F5){ref-type="fig"}D). Notably, within this shared gene set, the DNA repair pathway is prominent. Relevant in this regard are the *ku80* and *ku70* (*Irbp*) genes as well as *CG3448*, predicted to engage in the ligation step of double-strand break repair. Together, these observations indicate that DNA repair is a major stress-induced p53 program commonly shared by irradiated embryos and heads.

Basal p53 genome-wide DNA occupancy does not predict IR-responsive targets in postmitotic tissue
------------------------------------------------------------------------------------------------

p53 can either be prebound or be recruited to stress-response target genes ([@B80]; [@B89]).Therefore, to systematically examine constitutive p53 DNA occupancy and p53 IR-induced gene activation, we integrated our ChIP-seq and RNA-seq data sets (Supplemental File 2). We found that in embryos, only 14.5% of eRIPD genes contained TSSs within 5 kb of an e-peak ([Figure 6](#F6){ref-type="fig"}A) and, as expected, some of the top IR targets including the apoptotic program were among genes near a p53-binding site. More surprisingly, in heads, only one hRIPD gene (CG15456) was associated with a h-peak within 5kb of the TSS ([Figure 6](#F6){ref-type="fig"}A'). In addition, we examined whether p53 peaks correlated with constitutive gene expression differences between WT and p53^−/−^ (Supplemental Figure S7). In embryos only ∼2% of 572 genes basally affected by p53 loss were within 5kb of a p53 e-peak (these include genes with expression twofold higher or lower in p53^−/−^ compared with WT). Likewise, applying the same analyses in heads, we found only ∼3.4% of 583 genes affected by loss of p53^−/−^ within 5 kb of a h-peak. Notably, however, in both embryos and heads, most p53-binding sites were indeed found within 5 kb of a TSS (61.5 and 78.3%, respectively) ([Figure 3](#F3){ref-type="fig"}, C and C'). Therefore, despite a tendency for binding near genes, only a small portion of p53 peaks in both embryos and heads could predict p53-dependent gene expression.

![Most IR induced p53-dependent genes are distant from p53-binding sites. (A, A') Distances spanning from the TSS of indicated RIPD gene set and the nearest p53 ChIP peak are plotted. (B, B') Distances spanning from the TSS of the indicated RIPD gene set and a canonical p53 unsplit binding motif (associated with IR activation \[[@B89]\]). Note that genes having a peak/motif within 5 kb are boxed.](mbc-30-1339-g006){#F6}

We also sought to assess de novo recruitment of p53 binding in response to IR but, unfortunately, the capacity of our irradiator precluded treatment of sufficient numbers of adults flies needed to prepare high quality chromatin suitable for ChIP-seq studies. However, [@B89] found that IR-activated genes bound by p53 are more likely to contain the canonical motif with no spacer between the two decameric half-sites ([@B89]). Therefore, as an alternative approach, we probed the promoters of eRIPD and hRIPD genes for the presence of the unsplit p53 consensus (within 5kb of TSSs) ([Figure 6](#F6){ref-type="fig"}B). We found that 30.5% of eRIPD genes contain the p53 motif compared with 14.5% RIPD genes that are prebound by p53. In heads, 23.9% of hRIPD genes have the motif versus 1.09% that are prebound. These analyses raise the possibility that de novo p53 occupancy may be an important driver of stress-induced gene activation, especially in postmitotic tissue.

DISCUSSION
==========

We interrogated p53 function using RNA-seq and ChIP-seq studies to comparatively examine the action of p53 in postmitotic and embryonic tissues. In contrast with developing embryos---and despite significant DNA damage marked by γ-H2Av (Supplemental Figure S8A)---p53 did not trigger apoptotic programs in the adult fly head after radiation exposure ([Figures 1](#F1){ref-type="fig"} and [5](#F5){ref-type="fig"}). Mechanisms that specify distinct stimulus-dependent p53 programs in these tissues are not understood, but different levels and/or types of IR-induced DNA damage could be a contributing factor. We had previously shown in embryos that genetic loss of a single p53 enhancer (p53RE^rpr^) upstream of *rpr* abrogates p53 IR activation of not only *rpr* but also genes far away, such as *hid*, *skl, xrp1*, and *egr* ([@B48]; [@B49]). We had also shown that the p53RE^rpr^ enhancer forms long-range chromatin contacts to its targets ([@B49]). Interestingly, our ChIP-seq data in embryos revealed p53 binding not only at *rpr* but also at *hid*, *xrp1,* and *egr* ([Figure 4](#F4){ref-type="fig"} and Supplemental Figure S4). Strikingly, in heads, where all of these genes are unresponsive ([Figures 1](#F1){ref-type="fig"} and [5](#F5){ref-type="fig"}), p53 binding is maintained at each of these sites with the exception of *rpr,* where p53 occupancy at the p53RE^rpr^ was clearly lost ([Figure 4](#F4){ref-type="fig"}). Therefore, p53 binding at sites near *hid*, *egr* and *xrp1* is not sufficient to induce p53 target activation at these genes. Furthermore, since long range contacts between the p53RE^rpr^ and sites at *hid* and *skl* were unchanged in heads relative to embryos ([Figure 2](#F2){ref-type="fig"}A), chromatin folding does not appear to determine target activation either. Furthermore, the combined observation that p53RE^rpr^ loops are maintained in heads, while p53 binding to p53RE^rpr^ is lost, corroborates our previous observations that p53 DNA binding is not required for chromatin looping of the p53RE^rpr^ ([@B49]). Instead, our results suggest that p53 occupancy at the p53RE^rpr^ may act as the tissue-specific feature that licenses responsive loci within the *reaper* region. Consistent with this model, [@B102]a) reported that this genomic region is compacted by H3K9me3 as embryonic development proceeds. Furthermore, this epigenetic silencing of p53-regulated apoptotic genes is also detected in endoreplicative tissues of third-instar larvae ([@B101]).

Our RNA-seq studies revealed that in response to IR stress, *Drosophila* p53 can activate a diverse set of genes in adult heads ([Figure 5](#F5){ref-type="fig"} and Supplemental Figure S5). A significant portion of these genes, 88%, are unique to postmitotic tissue ([Figure 5](#F5){ref-type="fig"}D). Pathway-enrichment analyses determined that p53 activates DNA repair, metabolism and proteolysis genes as well as many uncharacterized genes ([Figure 5](#F5){ref-type="fig"}C). Importantly, many of the novel p53 target genes uncovered here have predicted human orthologues and some are associated with disease, including cancer (see Supplemental File 1). Interestingly, DNA repair appears to be a p53-driven program shared by proliferating and postmitotic tissues. The precise advantages of p53-mediated induction of DNA repair genes remain to be rigorously investigated ([@B30]) but may be critical for tumor suppression ([@B28]). We observed that bulk γ-H2Av phosphorylation showed similar kinetics in WT and p53^−/−^ heads up to 3 h postradiation (Supplemental Figure S8B), but defective DNA repair phenotypes beyond the detection limits of our assay or independent of the marker used are clearly possible ([@B99]). Intriguingly, human orthologues of several p53 stress-responsive targets ([Figure 5](#F5){ref-type="fig"}, A and B) are members of the Kallikrein (KLK) family of serine proteases (fly genes are alphaTry, betaTry, *yip7,* and *Jon25Bi*). KLK dysregulation and/or mislocalization have been associated with carcinogenesis and other pathologies including neurological disease ([@B38]), but they have not been defined as p53 targets. KLK3 (*yip7* and *jon25Bi*), also known as prostate-specific antigen, is a prominent biomarker for prostate cancer and may promote cancer evasion through interference in the p53 pathway ([@B63]; [@B18]). Additionally, KLKs have been implicated with other hallmarks of cancer, such as energy metabolism, angiogenesis, cancer invasion, and metastasis ([@B18]). It will be interesting to determine whether KLKs are p53 targets in mammals and whether KLKs are impacted by mutant p53 alleles. Another interesting target uncovered by these analyses is *CG3448,* which contains a XRCC4-like domain. In mice, *XRCC4* loss leads to embryonic lethality associated with massive apoptosis of early postmitotic neurons ([@B97]). Given the types of targets we uncovered through RNA-seq, it appears that p53 postmitotic programs are adaptive for cell survival and, therefore, studying p53 in this context could reveal mechanisms employed by p53 alleles that are thought to have oncogenic properties ([@B41]; [@B24]; [@B39]; [@B64][;]{.ul} [@B23]). Consistent with this, recent studies have uncovered a neuroprotective role of p53 in a *Drosophila* model of tauopathy ([@B58]). Intriguingly, the IR response found here is distinct from the pathways reported in those studies, underscoring the context specificity of the p53 regulatory network in vivo.

We also examined genome-wide p53 DNA occupancy and integrated these data sets with corresponding RNA-seq data sets to determine how preconfigured enhancer networks may dictate tissue-specific responses. A powerful advantage in these studies is that all p53 peaks were called in relation to p53^−/−^ ChIP-seq data sets produced in parallel. As expected, p53 was heavily enriched close to TSSs with 135 e-peaks (in embryos) and 393 h-peaks (in heads) ([Figure 3](#F3){ref-type="fig"}). In embryos, p53 was poised at apoptotic genes as well as several top IR-induced targets (e.g., *rpr, hid,* and *eiger*). However, unlike the p53RE^rpr^ enhancer where tissue-specific binding predicted transcriptional regulation of the proximal gene *rpr*, p53-mediated gene expression could not be generally inferred from the DNA-binding location alone and, in heads, only one IR-responsive gene was prebound by p53. This gene, CG15456, has not been functionally studied but, notably, a human orthologue designated *MIEN1* (migration and invasion enhancer 1) is an oncogene associated with breast, colorectal, and oral cancers ([@B32]; [@B15]; [@B71]).

As seen in other models, our data exposed relatively low correlations between p53 binding and nearby p53-dependent gene expression ([@B89]). Several explanations could account for the discordance between p53 binding and IR-activated genes. First, transcriptional regulation could be imposed by looping of long distance enhancers. In mammalian cells and in *Drosophila*, for example, regulatory contacts spanning 430 kb and even across chromosomes have been documented ([@B49]; [@B56]). Second, stimulus-dependent binding could govern regulatory targets and, while technical limitations prevented us from profiling p53 occupancy after radiation (discussed above), our computational evidence is certainly consistent with this ([Figure 6](#F6){ref-type="fig"}B). Third, some targets could represent indirect responses. Taken together, these analyses underscore the danger of solely relying on p53 binding to predict gene regulation.

Interestingly, when we performed pathway-enrichment analyses to determine programs bound by p53 in postmitotic tissue (genes within 5 kb of a ChIP peak), we detected many developmental genes. Given that p53 function in development has been reported ([@B88]; [@B14]), it will be interesting to study whether occupancy at these sites represents residual binding from p53 functions performed during development. Together, these genome-wide analyses establish the *Drosophila* head as a useful in vivo model to dissect p53 stress responses in postmitotic tissues.

MATERIALS AND METHODS
=====================

Fly stocks
----------

Flies were kept at 18--25°C and fed standard medium. The *p53*^ns^ allele ([@B83]) and the parental wild-type strain *w*^1118^ were used for experiments in [Figures 1](#F1){ref-type="fig"}, C and D, and 2A. All other experiments were performed using the *p53*^5A-1-4^ allele ([@B96]) paired with the parental wild-type *yw* strain. Flies were 1--2 wk old; genotypes were age-matched in each experiment.

TUNEL
-----

Staged yw embryos (3--4 h) and adult yw flies (5--10 d) were treated with 40 Gy of IR and recovered for 1.5 h. Brains were dissected in cold HL-3 buffer ([@B84]) and fixed for 1 h at room temperature in 4% paraformaldehyde PBST (1× PBS and 0.3% Triton X-100). Three washes were performed (10 min each) in PBST. Fixed brains were kept overnight in cold 1× PBS.

Embryos were dechorionated using 50% bleach, followed by a thorough wash with distilled water and fixed for 20 min at interface of n-heptane and 4% formaldehyde in 0.1 M PO~4~ (pH 7.2) (72% Na~2~HPO~4~, 28% NaH~2~PO~4~) on a shaker platform in glass tubes. The vitelline membrane was removed using the methanol cracking method. The next day, embryos were transferred to PBST through gradual methanol series (75, 50, and 25% MeOH PBST, 5 min each wash). Then three washes were performed (10 min each) in PBST.

TUNEL labeling was performed using Millipore's kit FragEL DNA Fragmentation Detection Kit, Fluorescent. Briefly, samples were treated with proteinase k (1:100 in PBST), followed by four quick washes in PBST. A postfixation step was performed using 4% formaldehyde in PBST for 20 min at room temperature, followed by three washes (5 min each) in PBST. Tissue was equilibrated in TdT labeling solution for 30 min at 37°C without enzyme. Next, 30 µl of TdT labeling solution containing 3 µl of TdT enzyme was added to samples, and an incubation was performed at 37°C for 2 h. Finally, four washes were performed using PBST (15 min each) at room temperature (diamidino-2-phenylindole \[DAPI\] stain performed in the third wash). Brains were mounted with tape spacers in RapiClear (SunJin lab) and imaged using a Leica Sp8 (25× water lens) with 2-µm sections through the whole brain. Resulting stacks were analyzed using Imaris (Bitplane). After Gaussian smoothing, the Imaris Spots function was used to quantify TUNEL-positive cells in each brain.

RT-PCR
------

For IR stimulus, flies were treated with 40 Gy of γ-radiation. Total RNA was extracted from the tissue of interest using Invitrogen's TRIzol reagent according to the manufacturer's protocol. Next, samples were treated with Ambion's TURBO DNA-free kit. cDNA synthesis was performed with Bio-Rad's iScript Reverse Transcription Supermix for RT-qPCR. Droplet digital PCR (ddPCR) was performed using Bio-Rad's EvaGreen system. Gene expression of each RIPD gene was normalized to rp49 expression, and fold induction was calculated comparing IR and mock samples in each genotype (primer sequences are listed in [Table 1](#T1){ref-type="table"}). All graphs containing error bars constitute two to three biological replicates; each biological replicate represents 15--50 animals homogenized together. Statistical significance was determined through multiple *t* test calculated using GraphPad Prism Software. Alternatively, conventional PCR using Promega goTaq DNA polymerase was used to assay gene expression by gel electrophoresis.

###### 

RT-PCR primer sequences.

  Target         Primer sequence
  -------------- ---------------------------------------
  rp49 FWD^a^    ATG ACC ATC CGC CCA GCA TAC A
  rp49 REV^a^    CGT AAC CGA TGT TGG GCA TCA GAT ACT
  hid FWD^a^     GAT GGG GAT TCG AGT TCG GAT TCG GAT
  hid REV^a^     CAC TGC CCA CCG ACC AAG TGC TAT A
  rpr FWD^a^     GTG TGC GCC AGC AAC AAA GAA CTA
  rpr REV^a^     TTG CGA TGG CTT GCG ATA TTT GCC
  skl FWD^a^     GAG AGA ATG AGC GAG ACA GTG ACA GAG A
  skl REV^a^     TCG ATT TGA AAA CTA GCG ACT GCT TAC A
  xrp1 FWD^a^    CAT TAC CAA CAT CAA GCG TTC TGC TCC G
  xrp1 REV^a^    TGT TGC TGG TGC TGG TAC TGG TAC TT
  ku80 FWD^a^    TGT GTG GCG GAG ATT CTT AAG GA
  ku80 REV^a^    ATC CTC GCA GGC TGT CTT ATT CAC A
  ku70 FWD       AGG GCA AGG AGT TCG AGT TT
  ku70 REV       GGA AGG CGT CCA GTT CGA TA
  RnrL FWD       TAA GAG AGA TGG CAG GCA GG
  RnrL REV       CCA TTG ATG ACT TGC AGG GTG
  CG3448 FWD     ACT TCA ACG CTC TCA GCT CTC
  CG3448 REV     CGT CGT CCA TCC ATT TGC TTC
  BetaTry FWD    CCT CCT ATG GCT ACG GAA ACC
  Beta Try REV   CAG CAC ATC CGT ATC CCC AG
  Yip7 FWD       CCA TCA TCG GAA ACG AGT GGG
  Yip7 REV       CTT GGG TGA ACT CGG GGC TA

^a^Published in [@B49].

RNA-seq
-------

Approximately 100 fly heads were homogenized together per condition (yw and p535A-1-4, mock/IR treated). Embryos of the same genotypes were collected in standard grape juice agar plates and staged 3--4 h when IR/mock treatment was applied; animals were then allowed to recover for 1.5 h and were dechorionated using 50% bleach. RNA was extracted following the same Trizol protocol described above. After treatment with Ambion's TURBO DNase kit, an isopropanol precipitation was performed. Next, 1 µg of total RNA was used for library preparation following standard Illumina protocols for poly (a)-stranded paired-end RNA-seq (reading length of 150 base pairs). One collection was processed and sequenced for each condition/genotype.

Sequenced read pairs were preprocessed to remove adapters using Cutadapt ([@B54]) and low-quality reads or bases with Prinseq ([@B79]). Sequence alignment was to the Drosophila genome dm6 (Illumina) using Tophat2 and the parameters *-p 10---mate-inner-dist = 200---mate-std-dev = 40---library-type fr-firststrand---no-coverage-search* ([@B36]). The open-source Picard toolkit was used to mark PCR duplicates, which were removed using SAMtools along with low-quality alignments (quality score below 25) prior to downstream analyses ([@B43]; [@B66]).

Differential gene expression analyses were performed using the Cuffdiff program ([@B90]) through the UT Southwestern Medical Center's BioHPC Galaxy Service (galaxy.biohpc.swmed.edu) ([@B1]). The library normalization method was geometric with blind dispersion estimation, and bias correction was performed. For analyses of p53 target activation, genes with expression values below 2 in all data sets were excluded as well as noncoding RNAs. A pseudocount of 1 was added to all gene expression values. The fold change was calculated between IR and mock IR samples, and a cutoff of 2′ fold change was used. For basal gene expression analyses, fold change was calculated between p53^−/−^ and WT, and the cutoff used equaled 2′. We annotated biological functions of genes of interest using the batch download tool at Flybase (FB2017_02) ([@B21]).

GOrilla ([@B16])
----------------

We performed GO analyses using the two unranked lists of genes mode of GOrilla. Below is the description from results provided by the GOrilla web tool:*p* Value is the enrichment *p* value computed according to the mHG or HG model (not corrected for multiple testing of 6948 GO terms).FDR *q* value is the correction of the above *p* value for multiple testing using the Benjamini and Hochberg (1995) method. Namely, for the *i*th term (ranked according to *p* value), the FDR *q* value is (*p* value \* number of GO terms)/i.

ChIP
----

We adapted previously published ChIP protocols ([@B12]; [@B61]). Starting with ∼30 ml of adult flies, Drosophila heads were separated by flash-freezing on liquid nitrogen, followed by vigorous vortexing and sieve-sorting (Hogentogler, number 30 on the top and number 40 on the bottom). Next, heads were homogenized while being fixed in 10 ml of 1% formaldehyde in 60 mM KCl, 15 mM NaCl, 4 mM MgCl~2~, 15 mM HEPES (pH 7.6), 0.5% Triton X-100, and freshly added 0.5 mM dithiothreitol (DTT) and EDTA-free protease inhibitors (Roche). Tissue was mechanically disrupted in a ground glass homogenizer (five strokes) and then in a Douncer with type A, loose, pestles (10 strokes). Fixation step together with homogenization totaled 15 min. Fixation was stopped with the addition of glycine to 225 mM and 5 min incubation on ice. Nuclei were recovered by centrifugation at 4000 × *g* for 5 min at 4°C. Nuclei were washed three times with 3 ml of the same buffer used during fixation without formaldehyde. Next, nuclei were washed once with 3 ml of lysis buffer (140 mM NaCl, 15 mM HEPES, pH 7.6, 1 mM EDTA, 0.5 mM EGTA \[ethylene glycol tetraacetic acid\], 0.1% sodium deoxycholate, 1% Triton X-100 and freshly added 0.5 mM DTT, and protease inhibitors). Then, nuclei were resuspended in 900 µl of sonication buffer (lysis buffer + 0.1% SDS and 0.5% N-lauroylsarcosine). Samples were incubated for 10 min while rotating at 4°C. Sonication was performed in three 1.5-ml Eppendorf tubes (300 µl of sample each) with the Diagenode Bioruptor for 45 min at high, 0.5 min on/off. After sonication, samples were again incubated while rotating for 10 min at 4°C. Next, debris was spun down for 5 min at 4000 × *g* at 4°C and the supernatant was transferred to a clean tube. The pellet was resuspended in 900 μl of sonication buffer and incubated while rotating for 10 min at 4°C. Samples were pelleted again and the supernatant was transferred and combined with supernatant from the previous step. The combined supernatant was centrifuged two more times at max speed for 10 min each time. One percent of the sample was kept for the input control, and the rest was split evenly for immunoprecipitation (using 2 µg of *Drosophila* anti-p53 d200 from Santa Cruz and normal rabbit IgG also from Santa Cruz). Immunoprecipitation was performed overnight on a nutator at 4°C. The next day, 60 µl of Santa Cruz Protein A/G beads slurry (rinsed with lysis buffer) was incubated with samples for 4 h on a nutator at 4°C. Beads were washed three times with lysis buffer 5--10 min each and once with TE buffer on a nutator at 4°C. Beads were eluted with 100 µl of elution buffer (20 mM Tris--HCl, pH 7.5, 5 mM EDTA, and 50 mM NaCl and freshly added 1% SDS, 50 µg/ml Proteinase K, and 20 µg/ml RNase A) for 10 min at 65°C in a thermoshaker at 900 rpm twice. Eluate was kept at 65°C in a thermoshaker at 900 rpm overnight for de-cross-linking. The next day, a standard phenol/chloroform extraction was performed, followed by isopropanol precipitation of the ChIP DNA with added glycogen.

Embryos were collected and staged to 4--6 h, dechorionated with 50% bleach, followed by a thorough wash with distilled water. Embryos were then prepared according to the ChIP protocol described above.

ChIP enrichment was quantified by Bio-Rad's ddPCR with EvaGreen system, following manufacture's guidelines. Primers used are listed in [Table 2](#T2){ref-type="table"}. Statistical significance was determined through paired *t* test, calculated using GraphPad Prism Software.

###### 

ChIP-PCR primer sequences.

  Target                Primer sequence
  --------------------- ---------------------------------
  p53 promoter FWD^a^   CGCTTGTACTTGCATCATTCG
  p53 promoter REV^a^   GCGCCTTGGCTGGATAAAC
  3′ UTR FWD^a^         GTGGCAGCCGGTCGAA
  3′ UTR REV^a^         CAGCCAAAGCGGATGCA
  p53RE^rpr^ FWD^a^     CGGAAAACTGATATGGCGATAAG
  p53RE^rpr^ REV^a^     CGGTCCCTCAGTCTCCAAGTC
  CG3967 FWD            GGC ATT GAA ATA CTT TTT GCG GTC
  CG3967 REV            TCG TTT GCG ATC GTT CCG TT
  corp FWD              TTG TTG CTC TAC GCC AAG CG
  corp REV              ATT AAA CTC GTG CCA CCC CA
  CG13204 FWD           GTG TGC ATG CAG CTC TCG
  CG13204 REV           ATC GGA ATC TGC CAA CCG TC
  Mhc FWD               GTT GTG TCG GAA CTC ATC CCT
  Mhc REV               AGA TGA GCT GCG GTT GAT TGA
  lok FWD               TTG AAA AGT GCG TTC CTA GCG
  lok REV               AGT TCT TGA TGG CTC AGG CG
  RpL10Aa FWD           AGT GCA GGA GTC TGC CCA TA
  RpL10Aa REV           TTC TCT GTT GTG GGT GTC GC

^a^Primer sequences were first published in [@B58]).

ChIP-seq
--------

ChIP DNA was quantified using the Promega's QuantiFluor ONE dsDNA System according to the manufacturer's protocol. Then, 10 ng of ChIP DNA was used to prepare next-generation sequencing (NGS) libraries following previously published protocols ([@B50]; [@B69]). Libraries were amplified with eight PCR cycles. ChIP libraries were sent for sequencing on Illumina NextSeq 500 at the McDermott Center NGS Core at UT Southwestern Medical Center. One collection (30 ml adults) was processed sequenced for each condition/genotype.

Sequencing read pairs were preprocessed to remove adapters using Cutadapt ([@B54]) and low-quality reads or bases with Prinseq ([@B79]). Sequence alignment was to the *Drosophila* genome dm6 using Bowtie2 ([@B40]). The open-source Picard toolkit was used to mark PCR duplicates, and downstream analyses were performed on uniquely mapped reads ([@B66]). MACS2 was used to call peaks with the --nomodel and --ratio flags ([@B102]b). The NCIS scaling ratio was calculated for each negative control and ChIP comparison using the NCIS R package ([@B47]; [@B74]). Fold enrichment bedGraphs were created using the MACS2 bdgcmp subroutine using the procedure outlined in the MACS2 documentation and converted to bigwig format with the UCSC bedGraphToBigWig program ([@B33]). Individual signal tracks were created in deeptools using bamCoverage (--*binSize 10 --smoothLength 30 --normalizeUsing CPM --extendReads 200*) ([@B72]). Distance to nearest MACS2 peak was determined for all unique TSS of protein-coding genes in the RefSeq annotation of the *Drosophila* genome using BEDtools ([@B70]). Motif search was performed using Homer with the custom p53 motif matrix ([@B25]):

  ------------------------------------ -------- ------- --------
  \>GGACATGCCCAGACATGCCC dp53(p53) 8                    
  0.33                                 0.1736   0.33    0.1664
  0.275                                0.108    0.421   0.198
  0.481                                0.052    0.334   0.135
  0.019                                0.826    0.07    0.086
  0.657                                0.118    0.056   0.17
  0.221                                0.028    0.099   0.653
  0.002                                0.003    0.99    0.006
  0.077                                0.406    0.021   0.498
  0.15                                 0.535    0.078   0.238
  0.168                                0.36     0.132   0.341
  0.348                                0.137    0.341   0.175
  0.241                                0.078    0.526   0.156
  0.499                                0.022    0.405   0.076
  0.007                                0.987    0.004   0.003
  0.652                                0.1      0.029   0.22
  0.165                                0.054    0.108   0.674
  0.083                                0.046    0.854   0.018
  0.126                                0.343    0.057   0.476
  0.211                                0.416    0.109   0.266
  0.19                                 0.349    0.138   0.325
  ------------------------------------ -------- ------- --------

### Chromosome Conformation Capture (3C)

#### Tissue preparation.

Starting with 5 ml of whole flies, *Drosophila* heads were separated from bodies by flash-freezing on liquid nitrogen, followed by vigorous vortexing and sieve-sorting. The intact heads were cross-linked in 1 ml of the following buffer: 2% formaldehyde, 50 mM HEPES, pH 7.6, 100 mM NaCl, 0.1 mM EDTA, and 0.5 mM EGTA during 15 min at room temperature in the vortex (gentle mixing). Formaldehyde was quenched by rinsing tissue in 1 ml of 1× PBS, 0.01% Triton X-100, and 0.125 M glycine two times. Next, tissue was incubated on ice for 15 min in lysis buffer (10 mM Tris, pH 8.0, 10 mM NaCl, 0.2% NP40, fresh protease inhibitors). Then, mechanical lysis was performed with a glass homogenizer with type A, loose, pestles (10 strokes). Lysate was spun down for 5 min at 4000 × *g* in 4°C to recover nuclei. The supernatant was discarded.

#### Digestion.

Nuclear pellets were resuspended in 1 ml of 1.2× *Hin*dIII digestion buffer. Then, each sample was split into four tubes and the final volume of each tube was brought up to 350 μl of 1.2× *[Hin]{.ul}*dIII digestion buffer along with 0.3% SDS. Samples were incubated at 65°C for 10 min while shaking at 1100 rpm. Then, 2% Triton was added and samples were incubated at 37°C for 15 min shaking at 1100 rpm. Digestion was performed with 700 U of *Hin*dIII enzyme at 37°C overnight shaking at 1100 rpm. The following day, *Hin*dIII was inactivated using 1.6% SDS with incubation for 30 min at 65°C shaking at 1100 rpm.

#### Ligation.

Ligation was performed in final volume of 16 ml of the following buffer: 1× T4 DNA ligase buffer, 1% Triton X-100, and water. Samples were allowed to stand at bench for 30 min before adding ligase to allow Triton to sequester SDS. Next, 8000 U of T4 DNA ligase was added to samples, and incubation was performed at 16°C overnight.

#### Reverse cross-linking.

The following was added to reverse cross-link DNA: 0.2 M NaCl, 20 µg/ml RNase, and 120 µg/ml Proteinase K. Samples were incubated at 65°C for at least 4 h.

#### DNA purification.

To purify the 3C DNA, phenol/chloroform extraction was followed by ethanol precipitation. Last, samples were put through Invitrogen PCR clean-up columns to increase DNA purity. DNA quality was checked with gel electrophoresis and ddPCR dilution curves.

#### ddPCR.

Interaction frequency between the p53RErpr and our previously characterized regions was assayed by ddPCR according to our published protocol (probes and primers) ([@B49]). Controls for normalization and background assessment spanned a gene desert genomic locus, also from our previously published assay ([@B49]).

Western blot
------------

Whole cell or nuclear lysates were prepared from tissue of interest. The protein was quantified using the Bio-Rad Protein Assay according to the manufacturer's instructions with a bovine serum albumin standard curve. The protein lysate was separated by SDS--PAGE and transferred to Immobilon-P membranes (Millipore) using a standard wet transfer protocol. The membrane was blocked for 1 h at room temperature or overnight at 4°C while rocking (5% milk, 0.5% Tween-20, and 1× TBS). The membrane was rinsed twice and washed once for 15 min on a rocker (0.2% milk, 0.2% Tween-20, and 1× TBS). The primary antibody was diluted in 1% milk, 0.2% Tween-20, and 1× TBS and was incubated for 1 h at room temperature or overnight at 4°C on a rocker (1:500 anti-drosophilap53 \[C-11\] from Santa Cruz, 1:1000 anti-γ-H2Av \[UNC93-5.2.1\] from Development Studies Hybridoma Bank \[DSHB\], and 1:5000, anti-tubulin \[E7\] from DSHB). The membrane was rinsed in wash buffer twice and washed once for 15 min on a rocker at room temperature. Horseradish peroxidase (HRP)-conjugated secondary antibody diluted in 1% milk, 0.2% Tween-20, and 1× TBS was incubated for 30--60 min on a rocker at room temperature. Next, the membrane was rinsed twice with wash buffer and washed three times for 10 min each on a rocker at room temperature. HRP was detected using chemiluminescence according to the manufacturer's protocol. Membrane signal was capture and developed in GeneMate Blue Autoradiography Film. Last, films were scanned and analyzed in ImageJ software.
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*Akh*

:   adipokinetic hormone

ChIP

:   chromatin immunoprecipitation

DAPI

:   diamidino-2-phenylindole

ddPCR

:   droplet digital PCR

DSHB

:   Development Studies Hybridoma Bank

DTT

:   dithiothreitol

EGTA

:   ethylene glycol tetraacetic acid

eRIPD

:   embryonic radiation-induced p53 dependent

GOrilla

:   gene ontology enRIchment analysis

*hid*

:   Head Involution Defective

hRIPD

:   head radiation-induced p53 dependent

HRP

:   horseradish peroxidase

IR

:   ionizing radiation

KLK

:   Kallikrein

NGS

:   next-generation sequencing

NHEJ

:   nonhomologous end joining

*rpr*

:   Reaper

RT

:   reverse transcription

*skl*

:   Sickle

TdT

:   terminal deoxynucleotidyl transferase

TSS

:   transcription start site

TUNEL

:   terminal deoxynucleotidyl transferase dUTP nick end labeling.

WT

:   wild type.
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